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Abstract 
Bet3, a transport protein particle component involved in vesicular trafficking, contains a hydrophobic 
tunnel occupied by a fatty acid linked to cysteine 68. We reported that Bet3 has a unique self-
palmitoylating activity. Here we show that mutation of arginine 67 reduced self-palmitoylation of 
Bet3, but the effect was compensated by increasing the pH. Thus, arginine helps to deprotonate 
cysteine such that it could function as nucleophile in the acylation reaction which is supported by the 
structural analysis of non-acylated Bet3. Using fluorescence spectroscopy we show that long-chain 
acyl-CoAs bind with micromolar affinity to Bet3, whereas shorter-chain acyl-CoAs do not interact. 
Mutants with a deleted acylation site or a blocked tunnel bind to Pal-CoA, only the latter with slightly 
reduced affinity. Bet3 contains three binding sites for Pal-CoA, but their number was reduced to two 
in the mutant with an obstructed tunnel indicating that Bet3 contains binding sites on its surface. 
 
 
 
 
 
Key words: Golgi, vesicular transport, tethering, TRAPP, Bet3, palmitoylation, acyl-CoA 
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Introduction 
Bet3 was identified to be a component of the multi-subunit TRAPP (transport protein particle) 
trafficking complex that plays an important role for the recruitment of ER-derived vesicles to the 
Golgi apparatus [1-5]. Two TRAPP complexes have been characterised that differ in size, localization 
within the Golgi and function [2]. Both TRAPP complexes facilitate nucleotide exchange on the small 
GTPase Ypt1 [6-8]. X-ray crystallography with human and mouse Bet3 revealed a novel protein fold 
and, surprisingly, a long chain fatty acid covalently bound via a thioester linkage to the conserved 
residue cysteine 68. The carbon chain is not exposed at the surface of the molecule, but completely 
buried inside a hydrophobic tunnel [9, 10]. Acylated Bet3 forms homodimers and also heterodimers 
with structurally related, but non-acylated TRAPP subunits, such as TPC6/Trs33 [11-14]. 
A variety of fatty acids may be attached to cysteine residues of proteins through an acylation reaction. 
S-acylation (also termed palmitoylation) may be dynamic with rapid cycles of acylation and 
deacylation, in contrast to other hydrophobic modifications, i.e. myristoylation or isoprenylation. 
Palmitoylation controls targeting of the modified protein to membranes or membrane subdomains, 
affects protein-protein interactions and influences the stability of proteins [15]. Palmitoylation of 
proteins is also involved in intracellular transport. Pal-CoA, the lipid donor in the palmitoylation 
reaction, stimulates transport through the Golgi in vitro, supporting budding as well as fusion of 
vesicles. It was suggested that this stimulatory effect might be due to palmitoylation of a protein, 
which thereby gets activated to function in the transport reaction [16, 17]. 
Palmitoyl-CoA is capable of spontaneously S-acylating cysteine residues of several proteins and 
especially of peptides at their natural palmitoylation sites in vitro [18-25]. Most of these reactions are 
unlikely to operate inside cells. They are either too slow or require unphysiologically high pH values 
or Pal-CoA concentrations to account for palmitoylation in vivo. 
The family of DHHC-CRD proteins (polytopic membrane proteins with the sequence DHHC and a 
cysteine-rich domain) has been identified as acyltransferases for a variety of substrate proteins in yeast 
and mammals [26]. However, Bet3 is unique in this respect since it has strong self-palmitoylating 
activity also in vivo. Incubation of purified Bet3 with [3H]-palmitoyl-CoA leads to a rapid and 
complete attachment of fatty acids to cysteine 68 [27]. This conclusion was supported by a study on 
the palmitoyl proteome of S. cerevisiae. Various DHHC proteins were deleted, and the effect on 
palmitoylation of individual proteins was determined. Only Bet3 showed a palmitoylation that was 
undiminished in any of the DHHC-mutant strains strongly arguing in favour of an autocatalytic mode 
for its acylation [28]. 
The only mechanistic understanding of acylation reactions of proteins has been derived from structural 
studies on the N-myristoyl-transferase (NMT) which attaches the rare C:14 carbon chain via an amide 
linkage to an N-terminal glycine residue. NMT binds almost exclusively myristoyl-CoA with 
nanomolar affinity, the binding site contains all the elements responsible for acyl chain-length 
measurement. Acyl transfer occurs through the nucleophilic addition-elimination reaction: an 
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oxyanion hole formed by main-chain atoms of NMT polarizes the thioester carbonyl of Myr-CoA and 
stabilizes the transition state while deprotonation of the ammonium of the Gly acceptor is mediated by 
NMT’s C-terminal carboxylate [29].  
Here we have characterised the self-palmitoylation reaction of Bet3 in more detail. We found that Bet3 
has an inherent propensity to be autoacylated which is fine-tuned by amino acids located in the 
vicinity of the acylation site. Especially the conserved arginine 67 enhances the acylation reaction, 
probably by facilitating deprotonation of cysteine 68 such that it could function as a nucleophile 
attacking the carbonyl of the C-S bond in Pal-CoA. Acyl-CoAs containing long chain fatty acids bind 
with micromolar affinity to Bet3, whereas shorter-chain acyl-CoAs do not interact. Bet3 mutants with 
a blocked tunnel bind to Pal-CoA with only slightly reduced affinity and revealed two acyl-CoA 
binding sites instead of three calculated for wild-type Bet3. We conclude that Bet3 contains acyl-CoA 
binding sites on its surface which might be required to extract Pal-CoA from intracellular membranes. 
Our findings might be helpful to understand palmitoylation performed by DHHC proteins which are 
promising, but poorly characterised drug targets [26]. 
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Materials and Methods 
Recombinant protein expression 
For expression of GST fusion protein in E. coli, human Bet3 cDNA was cloned into the bacterial 
expression vector pGEX-4T1 (GE Healthcare, Munich, Germany). Site-directed mutagenesis was 
performed by overlap extension PCR [30]. E. coli BL21 (DE3) cells were transformed with the 
resulting plasmids. An overnight culture was inoculated in YT medium containing 100 µg/ml 
ampicillin. The preculture was diluted 20-fold in the same medium, grown to OD600 0.7 at 37 °C, and 
induced with 1 µM isopropyl-β-D-thiogalactopyranoside. Growth was continued for 3 h, cells were 
harvested by centrifugation, and pellets were stored at -80 °C. To obtain GST-Bet3 cells were lysed 
using a French press (SLM-AMINCO) in PBS (phosphate buffered saline) supplemented with 1 mM 
PMSF, 1 mM DTT and DNAse I (Roche). A cleared lysate obtained by centrifugation was loaded on 2 
ml glutathione-Sepharose (Amersham) in a polypropylene column. The column was washed with PBS, 
protein was eluted with elution buffer (50 mM Tris pH 8, 10 mM GSH), and elution fractions were 
dialyzed against 25 mM Tris, pH 8.4, 120 mM NaCl. 
To obtain Bet3 without GST-tag the following procedure was used: In some experiments cells 
expressing GST-Bet3 were lysed by sonication in PBS supplemented with 1 mM PMSF, 1 mM DTT, 
and DNase I (Boehringer, Mannheim, Germany). A cleared lysate obtained by centrifugation was 
loaded on 5 ml of glutathione-Sepharose (GE Healthcare) in a polypropylene column. The column was 
washed with PBS. GST was cleaved by on-column incubation with 100 U thrombin over night at room 
temperature. Protein was eluted with elution buffer (50 mM Tris, 1 M NaCl, pH 7.4) over a 1 ml 
HiTrap benzamidine column (GE Healthcare), to retain thrombin. Protein solutions were concentrated 
and the buffer exchanged to PBS with Amicon Ultra Centrifugal Filter devices (10,000 MWCO) 
(Millipore).  
 
Palmitoylation assay 
[3H]-Pal-CoA, prepared as described [22], was dried in a SpeedVac and dissolved in 20 mM Tris-HCl 
(pH 7.4), 120 mM NaCl, 0.05% Triton X-100 to yield a final concentration of 100,000 CPM/µl. The 
palmitoylation reaction included purified protein, GST-Bet3 wild type and mutants, (0.5–8 µl, 10 µg, 
4 µM), 5 µl of [3H]-Pal-CoA (1 µM, 500,000 CPM), and 1 mM DTT in a final volume of 100 µl of 
PBS buffer and was incubated for 20 min at 30 °C. One ml of chloroform/methanol (1:1) was added to 
the samples, and precipitated proteins were pelleted (15 min, 14,000 × g), washed, resuspended in 20 
µl of non-reducing SDS-PAGE sample buffer, and boiled for 5 min. Samples were subjected to SDS-
PAGE, staining with Coomassie, and fluorography for 5 – 48 h. The palmitoylation assays shown in 
figures 1-3 and 5-7 were performed at least two times with similar results. 
 
Structure determination 
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The Trs33B:Bet3C68A complex was purified essentially as described before [13]. The protein was 
concentrated to 12 mg/ml in buffer containing 20 mM Tris, 200 mM NaCl, 2 mM DTT, pH 7.5 and 1 
mM Myr-X-CoA, a non-hydrolysable myristoyl-CoA thioether. Crystals were obtained at 20 ºC by the 
sitting-drop method using a semi-automated dispensing system [31] in conditions containing 22% 
PEG3350, 0.2 M Li2SO4, 0.1 M Bis-Tris pH 6.5. Crystals were flash-frozen in liquid nitrogen in cryo 
solution containing 20% PEG3350, 15% glycerol, 0.2 M Li2SO4, 0.1 M BisTris pH 5.6, 250 µM Myr-
X-CoA, and data were collected at ESRF BM14. Initial phases were obtained using Phaser [32] with 
the Trs33B:Bet3 complex (PDB: 2CFH) as a search model. After model bias removal 
(http://tuna.tamu.edu/), the final structure was obtained in several rounds of model building with Coot 
[33] and refinement using REFMAC5 [34]. The coordinates and diffraction amplitudes were deposited 
in the Protein Data Bank with accession code 3KXC. 
 
Fluorescence spectroscopy 
Purified Bet3 was diluted with Tris buffer (5 mM Tris, 100 mM NaCl, pH 7.4) to a concentration of 10 
µM. Measurements were carried out with a Cary Eclipse Fluorescence spectrophotometer (Varian) at 
room temperature using a quartz glass cuvette (100 µl volume). Samples were excited at 295 nm, and 
the emission scanned in the range of 310–450 nm. Each scan was repeated five times, and scanned 
graphs were averaged. Emission maxima were read out at 344 nm. Emission of the protein was 
recorded and then the acyl-CoA concentration increased stepwise by adding 1 µl of stock solution (in 
Tris buffer, concentration 1 mM to 100 mM). The reduction of the fluorescence intensity was 
normalized (F0–F/F0; F0: fluorescence intensity without ligand, F: fluorescence intensity at a certain 
acyl-CoA concentration) and plotted against the acyl-CoA concentration. Taking substrate depletion 
into account, the following equation can be derived for acyl-CoA binding to Bet3 [35]: 
 
 
 
where KD denotes the apparent dissociation constant for acyl-CoA, L and P denote the ligand and 
protein concentration, respectively, n is the number of ligand binding sites per protein, and Ymax is the 
final level of the relative fluorescence change. In all fits using Prism (GraphPad), protein 
concentration was fixed to 10 µM and KD, n and Ymax were allowed to vary. The results shown were 
calculated from at least three different experiments. 
 
Circular dichroism 
For circular dichroism spectroscopy, protein samples of human Bet3 purified from E. coli were diluted 
to 0.16 mg/ml in PBS buffer. Measurements were carried out with a Jasco J720 spectropolarimeter at 
20 °C from 200 nm to 260 nm with a 0.2 cm path-length cuvette. 
 
( ) ( )
max
2
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4
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Results 
Characterisation of the mechanism of the Bet3 self-palmitoylation reaction 
Insertion of the fatty acid of Pal-CoA into the hydrophobic tunnel, leaving the CoA moiety outside, 
would be a plausible mechanism to initiate self-palmitoylation of Bet3. This would position the 
thioester bond of the Pal-CoA molecule at the entrance of the tunnel where the fatty acid acceptor, 
cysteine 68, is located. Acyl-chain transfer then might occur through nucleophilic attack of the sulphur 
of cysteine 68 on the carbonyl-C of the C-S bond in Pal-CoA to catalyse the generation of acylated 
Bet3. It has been postulated that, besides availability of an activated fatty acid (acyl-CoA), the 
formation of a deprotonated cysteine (a thiolate) controls S-acylation [36]. Free cysteine has a pKa 
value of 8.5 so that deprotonation occurs infrequently at the neutral pH of the cell. However, the 
apparent pKa values may differ widely for individual cysteines present inside a peptide chain because 
the local environment strongly influences deprotonation of the SH group [37]. 
We first analysed the effect of thiolates on self-palmitoylation of Bet3 by facilitating their formation 
using buffers with decreasing proton concentration. We compared wild-type GST-Bet3 and mutants 
with modifications of the acylation site. Cysteine 68 was changed to alanine (C68A), or to serine 
(C68S) which, due to its hydroxyl group retains a potential acylation site. The palmitoylation assays 
were performed with GST-Bet3 fusion proteins, since the GST tag provided stability and protection 
against proteolytical degradation. However, performimg the assays with Bet3 alone produced identical 
results (not shown). Another mutant contained glutamic acid instead of the strictly conserved arginine 
in the vicinity of the acylation site (R67E). Figure 1A depicts the structure of Bet3 with the location of 
mutated amino acids highlighted. 
Purified proteins were incubated with [3H]-Pal-CoA in buffer adjusted to pH 6.5, 7.5 or 8.5 for 20 min, 
and samples were subjected to SDS-PAGE and fluorography. At pH 6.5 only palmitoylation of wild-
type Bet3 was readily detectable. The R67E mutant showed reduced acylation at neutral pH, probably 
by affecting deprotonation of cysteine 68. With increasing pH acylation of the mutants C68S and 
R67E becomes obvious, and at pH 8.5 it is almost as strong as the acylation of Bet3 wt (Fig. 1B). Even 
faint acylation of C68A becomes apparent at pH 8.5, probably representing background acylation 
occuring at other cysteine residues. Two additional cysteines are found in human Bet3, residue 31, 
which is partially surface-exposed, and residue 132, which is in the center of the protein so that 
unfolding at unphysiological pH would be a prerequisite for its palmitoylation. 
Deprotonation of Cys 68 might be facilitated when amino acids in its vicinity serve as acceptor of the 
proton. Such a function has been proposed for the carboxylate present at the C-terminus of the N-
myristoyl transferase which accepts a proton from the designated acylation site in the protein, in this 
case the ammonium of an N-terminal glycine residue [29]. Likely candidates for a role as proton 
acceptors apparent from the structure of Bet3 are His 69, and the acidic amino acids Asp 70 and Glu 
73 (Fig. 1A). In contrast to His 69, which is not present in yeast Bet3, Glu 73 and especially Asp 70 
are partially conserved within Bet3 orthologs and were therefore mutated to their respective amides. 
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However, these Bet3 mutants were acylated at neutral pH to a similar (E73Q), or even slightly higher 
(D70N) extent as compared to Bet3 wt (Fig. 1C).  
In the next set of experiments the self-palmitoylation activity of each Bet3 mutant was compared at 
various pH values between 5.5 and 9.5 (at more basic values the self-palmitoylation activity of Bet3 is 
inhibited [27]). Palmitoylation of wild-type Bet3 increased gradually up to pH 8.5, where it reached a 
plateau, indicating an apparent pKa of the reaction in the neutral range. The pH profiles of Bet3 
mutants R67E, C68S and C68A are shifted toward basic pH, which is most evident for the C68A 
mutant (Fig. 2A). In contrast, the pH profiles of D70N and E73Q mutants are shifted toward acidic pH 
(Fig. 2B), an observation that was even more striking when both amino acids were exchanged 
simultaneously (D70N-E73Q). The results suggest a specific influence of the mutations on the 
apparent pKa value of the palmitoylation reaction. 
Self-palmitoylation of Bet3 proceeds rapidly, i.e. incorporation of [3H]-palmitate saturates in less than 
ten minutes (Fig. 3 and [27]). In contrast, acylation of Bet3 mutants R67E, C68S and A82L, a mutant 
with an obstructed hydrophobic tunnel, advances much more slowly (Fig. 3), which suggests a 
reduced enzymatic activity. 
 
Structure of the Trs33B:Bet3-C68A dimer crystallised in the presence of a non-hydrolysable acyl-CoA 
analogue 
To provide a structural basis for the mechanism of Bet3 acylation we attempted the co-crystallization 
of the mutant in complex with non-hydrolysable myristoyl-CoA thioether (Myr-X-CoA) which binds 
to Bet3 as described below (see Fig. 5C). This protein-ligand complex should represent a reaction 
intermediate of Bet3 acylation. We determined the structure at 2-Ǻ resolution using molecular 
replacement with the Trs33B:Bet3 complex (Table 1). To reduce model bias, the palmitoyl chain 
occupying the hydrophobic tunnel and the α2-α3 loop containing the palmitoylation site were 
excluded from the initial refinement, and the model was submitted to the model bias removal server 
(http://tuna.tamu.edu/). Suprisingly, Myr-X-CoA was not present in the crystal, which was confirmed 
by generating an anomalous difference map from a data set collected at low energy (1.7 Ǻ): no sulphur 
signal from the ligand could be detected in the map (not shown). Nevertheless, the hydrophobic tunnel 
of Bet3 is occupied by an elongated density, which we found to be best accounted for by modelling a 
palmitate molecule (Fig. 4A). The palmitate was probably co-purified during the isolation of the 
protein from E. coli to stabilize the molecule [27]. Myr-X-CoA binds to Bet3 with higher affinity than 
palmitate (see Fig. 5 and 7, below), but the additional CoA moiety might have interfered with the 
formation of crystal contacts, which may have led to the formation of crystals containing palmitate 
instead. Although we did not achieve our goal to crystallize a Bet3-ligand complex, the first structure 
of the Bet3 C68A mutant has peculiar properties that might be interesting with regard to the 
mechanism of the acylation reaction. 
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Compared to the structure of wild-type Bet3, the α2-α3 loop containing the palmitoylated residue Cys 
68 as well as Arg 67 adopts a similar conformation in Bet3 C68A (Fig. 4B). Because there is no 
covalent bond to palmitate in the mutant structure, the entrance to the hydrophobic tunnel is left 
slightly wider open. In addition, the guanidino group of Arg 67 has rotated towards the carboxyl group 
of palmitate and towards the Cβ of Ala 68, which would represent the active centre during the 
acylation reaction of wild-type Bet3. Because Cys 68 and Arg 67 are adjacent residues their side 
chains are 7.2 Å apart, too far for a direct deprotonation of Cys 68. Thus, Arg 67 probably lowers the 
pKa of Cys 68 through electrostatic interactions and stabilizes the negative charge developing during 
thiolate formation and the acylation reaction. 
 
Characterisation of the substrate requirements of the palmitoylation reaction 
Next we analysed the chemical composition required for a lipid molecule to function as ligand of 
Bet3. Increasing concentrations of unlabeled acyl-CoAs were added to the in vitro palmitoylation 
reaction. Myr- (C 14:0), Pal- (C 16:0), Stear- (C 18:0) and Oleoyl-CoA (C 18:1) almost completely 
inhibited [3H]-palmitoylation of Bet3 at concentrations of around 10 µM (Fig. 5a) indicating that they 
compete with [3H]-Pal-CoA for a binding site. In contrast, only a slight inhibition of [3H]-
palmitoylation of Bet3 was observed when 1000-fold higher concentrations of acetyl- or octanoyl-
CoA were used (Fig. 5B). It cannot be inferred from these experiments that all long chain acyl-CoAs 
are actually transferred to Bet3. Since myristate was found as the prevailing fatty acid covalently 
linked to Bet3 purified from E. coli [9], it is likely that the other acyl-CoAs can also be utilized by 
Bet3. But their ability to react with Bet3 is not a prerequisite for binding of acyl-CoAs to Bet3: The 
Myr-CoA analogue Myr-X-CoA inhibited self-palmitoylation of Bet3 at only marginally diminished 
concentration compared to Myr-CoA (Fig. 5C).  
For a quantitative assessment of Bet3 palmitoylation, we employed fluorescence spectroscopy to 
analyse binding of the substrate to the protein. Bet3 contains only one tryptophan residue at position 
96, which is exposed at the surface of the molecule near the end of the hydrophobic tunnel (Fig. 1A). 
When excited at 295 nm, purified Bet3 (without GST) displayed a broad emission peak between 330 
and 360 nm (uppermost trace in Fig. 6a). Adding increasing amounts of CoAs with long chain fatty 
acids, i.e. Myr-CoA, Pal-CoA, Stear-CoA and Oleoyl-CoA to Bet3 quenched its intrinsic fluorescence 
gradually and yielded complete quenching at a final concentration in the lower micromolar range 
(shown exemplarily for Pal-CoA in Fig. 6A). In contrast, CoAs esterified to short carbon chains, i.e. 
acetyl-CoA (C 2:0, Fig. 6B) and octanoyl-CoA (C 8:0, not shown), did not completely quench the 
intrinsic fluorescence of Bet3, even at a final concentration of 10 mM. The reduction in fluorescence 
intensity was normalized and plotted against the acyl-CoA concentration (shown for palmitoyl- and 
acetyl- CoA in Fig. 6A–B, right panel). The data were fitted as described in “materials and methods” 
with an equation taking into account ligand depletion upon substrate binding. From the fitting, the 
number of acyl-CoA binding sites per protein and a value for the apparent dissociation constant for 
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acyl-CoA (KD) (comprised of the individual KDs of each acyl-CoA binding site) were obtained (Table 
2 and 3). 
When analysing the most common acyl-CoAs containing long chain, saturated fatty acids, i.e. Myr-
CoA, Pal-CoA and Stear-CoA, the intrinsic fluorescence of Bet3 was almost completely quenched at 
concentrations of around 50 µM. KD values of 2.0 µM (Myr-CoA), 1.8 µM (Pal-CoA) and 1.3 µM 
(Stear-CoA) were calculated indicating that they bound with similar affinity to Bet3 (see Table 2). 
Almost identical results (KD: 2.1 µM) were observed for an unsaturated acyl-CoA (oleoyl-CoA) 
indicating that a kink in the fatty acid does not diminish binding to Bet3. In contrast, KD values in the 
millimolar range were calculated for CoAs containing short acyl chains. (Fig. 6B and Table 2). 
Does self-acylation of Bet3 require activation of the fatty acid substrate? Addition of [3H]-palmitate 
did not label Bet3, even when 10-fold higher radioactivity compared to [3H]-Pal-CoA was used in the 
assay and when CoA and ATP were also present to possibly activate the fatty acid (data not shown). 
Free palmitate inhibited the palmitoylation reaction only at millimolar concentrations (Fig. 7A, left 
part). The other constituent of activated fatty acids, CoA, did not inhibit the self-palmitoylating 
activity of Bet3 either, even at concentrations of 10 mM (data not shown). 
Thus, the requirements for a substrate to react with Bet3 are a long chain fatty acid linked to CoA, 
neither the carbon chain nor CoA alone interacts with micromolar affinity. We also asked whether 
other fatty acid-containing compounds, especially those used as inhibitors of protein palmitoylation, 
interact with Bet3. Lyso-phosphatidylcholine and tunicamycin both contain a long acyl chain, either 
bound to glycerol or (via sugar moieties) to adenine, and both inhibit self-palmitoylation of Bet3, with 
a half maximal inhibition at a concentration of around 100 µM (Fig. 7B). In contrast, cerulenin, which 
contains an unsaturated, C8 carbon chain, does not inhibit the reaction, even at millimolar 
concentration. Cerulenin and tunicamycin are established inhibitors of fatty acid synthesis and N-
linked glycosylation, respectively, but have also been used by some as inhibitors of protein 
palmitoylation [38]. The presently most popular inhibitor of protein palmitoylation is 2-bromo-
palmitate [38], which also very efficiently blocks palmitoylation of Bet3 at low µM concentration 
(Fig. 7A) and binds to wild-type Bet3 with a KD value of 1.3 µM (Table 2). 
The palmitoylation reaction catalyzed by the yeast DHHC protein Akr1p is stimulated by ATP [39]. 
Surprisingly, however, ATP at concentrations of 10 mM completely inhibited self-palmitoylation of 
Bet3. The phenomenon was specific for the adenine trinucleotide and required a hydrolysable ATP, 
since GTP and ATPγs did not block the reaction (Fig. 7C). 
 
Determination of the number of Pal-CoA interaction sites in Bet3 and molecular requirements for 
binding 
We next investigated whether Bet3 mutants with blocked or diminished self-palmitoylation activity 
have also a reduced binding affinity for the substrate. First we asked whether covalent transfer of the 
fatty acids to Cys 68 is a prerequisite for binding of acyl-CoAs to Bet3. In the fluorescence 
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spectroscopy assay, Bet3 C68A revealed very similar KD values for binding of various acyl-CoAs 
compared to wild-type Bet3 (Fig. 6C and Table 2). Furthermore, binding of the other long chain acyl-
CoAs was not altered either, and short chain acyl-CoAs did not bind (Table 2). Thus, wild-type Bet3 
and Bet3 C68A have identical affinities for the lipid substrate, indicating that binding and fatty acid 
transfer are distinct events. 
Next we tested our initial assumption that insertion of the fatty acid moiety into the hydrophobic 
tunnel is a prerequisite for binding of Pal-CoA to Bet3. Surprisingly, measuring the affinity for Pal-
CoA of the Bet3 mutant containing a narrowed tunnel (A82V) revealed a KD value of 4.0 µM, close to 
that of wild-type Bet3 (Fig. 6C and Table 3). 
Since Bet3 A82V or A82L still shows residual self-palmitoylating activity at neutral pH [27], it is 
likely that the mutation does not sufficiently restrict the tunnel to completely exclude insertion of a 
fatty acid. In the crystal structure of the Bet3 A82V mutant, the protein indeed was found to be 
palmitoylated at cysteine 68, with an acyl chain occupying the hydrophobic tunnel 
(Kümmel/Heinemann, unpublished). We therefore engineered an additional mutation into Bet3 A82V. 
Alanine 138, which is located in the middle of the hydrophobic tunnel opposite to alanine 82, was 
replaced by the bulky amino acid valine (Fig. 8A) to completely bock the tunnel. In accordance with 
this consideration, self-palmitoylation of Bet3 A82V-A138V is completely blocked at neutral pH (Fig. 
8B). 
Since lack of acylation increases the inherent instability of the Bet3 molecule [27], we compared the 
overall structure of Bet3 A82V-A138V with wild-type Bet3 using circular dichroism (CD) 
spectroscopy. However, the CD spectra for both molecules were similar, no indications for a random 
coil formation were detected (Fig. 8C), which indicates that the secondary structure of Bet3 was not 
changed significantly by the mutation.  
Determination of the KD of the A82V-A138V mutant for Pal-CoA revealed a reduction in its affinity 
to values of 15.8 µM, indicating that it still binds to Pal-CoA with only marginally reduced affinity 
(Fig. 6C and Table 3). From the fluorescence spectroscopy assay and the model we used to fit the data, 
the concentration of bound Pal-CoA and the number of acyl-CoA binding sites per Bet3 monomer was 
calculated (Table 3). Whereas wild-type Bet3, non-acylated Bet3 C68A and Bet3 A82V apparently 
contain three binding sites per Bet3 monomer, their number was found to be reduced to two in the 
Bet3 mutant containing a completely blocked tunnel. This indicates that the hydrophobic tunnel is 
indeed a binding site for acyl-CoA, but that other sites with similar affinity exist as well, probably at 
the surface of the molecule. 
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Discussion 
In this study we have analysed binding of acyl-CoAs to Bet3 and investigated the chemical 
mechanism that allows transfer of the fatty acid from CoA to the acylation site of the protein, cysteine 
68. The self-palmitoylating activity of wild-type Bet3 is enhanced by increasing the pH to slightly 
basic values (Fig. 1 and 2) suggesting that palmitoylation requires the formation of a deprotonated 
cysteine. At unphysiologically high pH values (9.5) even the Bet3 mutant containing alanine at the 
original acylation site is palmitoylated (Fig. 2), indicating that Bet3 has an inherent propensity to be 
acylated. One factor that controls S-acylation of Bet3 is the pKa value at which thiolate formation of 
individual putative acylation sites occurs. The authentic acylation site of Bet3, cysteine 68, is 
apparently in an environment that allows deprotonation at neutral pH. Even a serine, that has a very 
high  pKa value of 14 as free amino acid, is acylated at only slightly basic values (pH 8.5) when 
introduced at this position (Fig. 1 and 2). Thus, amino acids in the vicinity of the acylation site 
facilitate deprotonation of Cys 68 and even of Ser 68. A candidate for such an activity is the strictly 
conserved arginine 67, which is required for efficient acylation of Bet3 at neutral pH (Fig. 1). The 
functional defect of Bet3 R67E can be complemented by increasing the pH to 8.5. Furthermore, the 
crystal structure of Bet3 C68A shows that the guanidino group of Arg 67 has rotated towards the 
acylation site (Fig. 4) as compared to a previously published structure of wild-type Bet3 crystallized in 
the same space group [11]. The subtle structural change can be attributed to the fact that the palmitate 
ligand is negatively charged. This probably resembles charged reaction intermediates, in contrast to 
uncharged, covalently linked palmitate in the wild-type structure. These observations are also 
consistent with the assumption that Arg 67 stabilizes deprotonation of Cys 68. Alternatively, arginine 
67 may polarize the carbonyl bond in the thioester linkage of Pal-CoA or stabilize the negative charge 
of a putative tetrahedral reaction intermediate. 
The moderately conserved amino acids Asp 70 and Glu 73 apparently do not act as acceptor for 
protons released by thiolate formation of Cys 68. In contrast to Arg 67, their exchange did not 
diminish self-palmitoylation of Bet3 and did not cause a shift in the pH optimum of the reaction to 
basic values (Fig. 1 and 2). Instead, we observed increased acylation at acidic pH, indicating that both 
amino acids might prevent acylation of Bet3 at unphysiologically low pH values. Thus, the inherent 
propensity of Bet3 to be autoacylated is fine-tuned by the amino acids Asp 70, Glu 73 and especially 
by Arg 67 such that it occurs more rapidly (Fig. 3) and at neutral pH, and therefore at conditions 
which allow self-palmitoylation of Bet3 inside cells.  
The second factor that controls efficient self-palmitoylation of Bet3 is enrichment of acyl-CoAs in the 
vicinity of putative acylation sites. The affinity of Bet3 for binding of Pal-CoA is relatively modest 
(micromolar, Fig. 6 and Table 2) compared to e. g. the N-myristoyl-transferase, which binds 
myristoyl-CoA with nanomolar affinity. However, the affinity of Bet3 for acyl-CoAs is approximately 
one order of magnitude higher compared to Pal-CoA concentrations inside cells (5-150µM) [40]. Bet3 
binds the most common long chain acyl-CoAs (and also palmitoylation inhibitors with long carbon 
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chains), but CoA alone or CoAs esterified to short carbon chains do not interact with Bet3 (Figs. 5–7). 
The binding properties of Bet3 thus reflect the fatty acid composition of most S-acylated proteins, 
which contain a variety of long chain fatty acids [15]. Since wild-type Bet3 and Bet3 C68A have 
identical affinities for their lipid substrate (Table 2), stable binding of acyl-CoAs does not require fatty 
acid transfer to the acylation site.  
Contrary to our initial assumption, Bet3 mutants with a blocked tunnel bound to Pal-CoA with only 
slightly reduced affinity and revealed two acyl-CoA binding sites instead of three calculated for wild-
type Bet3 (Table 3). This indicates that the hydrophobic tunnel is indeed a binding site for acyl-CoAs, 
but that other sites with similar affinity exist as well, probably at the surface of the molecule. 
Displaying the hydrophobic interaction potential of Bet3 revealed two continuous regions on its 
surface, which might interact with acyl chains (depicted green and blue in Fig. 8D). 
Do these presumed acyl-CoA binding sites at the surface of the molecule play a role for self-
palmitoylation of Bet3 inside cells? Since the cytosolic acyl-CoA-binding protein (ACBP) binds its 
ligand with nanomolar affinity, virtually every cytosolic acyl-CoA molecule exists in a complex with 
ACBP [40]. Thus, free acyl-CoAs are available for Bet3 only at intracellular membranes, such as the 
ER and the Golgi apparatus, where they are needed for the synthesis of phospholipids and also for 
DHHC-catalyzed S-acylation of proteins. Bet3 has an intrinsic membrane binding activity, which 
targets the protein to the same intracellular location [9, 10]. Bet3 probably does not penetrate deeply 
into the bilayer but resides at the membrane surface. If the interacting capacity of Bet3 for acyl-CoAs 
were confined to the hydrophobic tunnel, it would be difficult for the molecule to interact with acyl-
CoA’s fatty acid, which is embedded in the hydrophobic interior of the bilayer. In contrast, a high-
affinity acyl-CoA binding site on the surface of Bet3 might be more suitable to facilitate interaction 
with and extraction of acyl-CoAs from the membrane. 
How is it conceivable that an acyl-CoA molecule bound to the surface of Bet3 is inserted into the 
tunnel and its fatty acid transferred to cysteine 68? We have previously proposed a molecular model 
for the extrusion of the fatty acid from the hydrophobic tunnel of Bet3 [10]. The mechanism involves a 
rotation of approximately 30° in the kinked helix α2 about a hinge region close to residue Gly 52, 
coupled with a maximal displacement of approximately 9 Å that would open the hydrophobic tunnel. 
Although purely speculative, it is possible that non-acylated Bet3 contains an open tunnel. This state 
will be energetically highly unfavourable. Binding of acyl-CoAs to the surface of Bet3 might trigger a 
conformational change that allows helix α2 to rotate back to its original position whereby the fatty 
acid of an acyl-CoA molecule would be inserted into the hydrophobic tunnel. Narrowing or blocking 
the tunnel by introduction of bulky amino acids reduces acylation of Bet3, probably because the 
conformational change that causes fatty acid insertion is hindered. The conformational change might 
be also sensitive to the pH, since an extended hydrogen-bonding pattern seen in the Bet3 structure 
within the putative hinge region must be modulated to allow movement of helix α2. This assumption 
would explain how a partial restriction of the tunnel can be complemented by a slightly basic pH 
Page 13 of 32 Cellular and Molecular Life Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 14 
during the palmitoylation reaction. Insertion of acyl-CoA into the tunnel is a prerequisite for acylation, 
since Bet3 containing a completely blocked tunnel is not acylated (Fig. 8).  
As we already pointed out [10], there is some structural similarity between the palmitate-binding α-
helical face of Bet3 and the non-specific lipid transfer proteins (LTPs) from plants and mammals [41-
43]. LTPs bind a variety of lipids, including Pal-CoA, with dissociation constants in the micromolar 
range. A further similarity to Bet3 is their lipid-binding site, a hydrophobic tunnel extending through 
the protein and bending slightly in the middle. The hydrocarbon chain of each fatty acid is buried in 
the cavity, and the carboxyl group is localized at the aqueous interface in contact with surface residues 
and water molecules. In barley LTP, the binding pocket can contract or expand to accommodate fatty 
acids of various sizes. These conformational changes are accompanied by a bending motion in helix 
αA and structural adjustments at the C-terminus and at helix αC, which are similar to those proposed 
above for Bet3. It is thus conceivable that Bet3 is evolutionarily related to a lipid transfer protein. By 
mutational acquisition of a potential acylation site at the entrance of the tunnel and of amino acids that 
facilitate its deprotonation, Bet3 has gained a self-palmitoylation activity that is used to stabilize the 
structure of the molecule. Other subunits of TRAPP exhibiting the same fold, such as TPC5/Trs31p 
and TPC6/Trs33p, do not contain an acylation site. Self-palmitoylation is lost, and the collapse of the 
molecule onto an empty cavity is prevented by bulky hydrophobic side chains that occupy the tunnel 
accommodating palmitate in Bet3. 
In accordance with this assumption is our observation that the hydrophobic tunnel of the Trs33B:Bet3-
C68A dimer is occupied by non covalently bound palmitate (Fig. 4). Apparently, Bet3, which can not 
stabilize its structure by self-palmitoylation of cysteine 68, nevertheless inserts a fatty acid into the 
tunnel. Non covalently bound palmitate might be also present in purified wild-type Bet3, but this 
moiety can be exchanged by Pal-CoA, for which Bet3 has a much higher affinity, in order for self-
palmitoylation to occur. 
In summary, our results suggest the following mechanism mediating self-palmitoylation of Bet3. 
Acyl-CoA binds to the surface of the molecule, and its fatty acid is subsequently inserted into the 
hydrophobic tunnel. The thioester bond of the Pal-CoA molecule is now situated at the entrance of the 
tunnel where the fatty acid acceptor, cysteine 68, is located. Facilitated by amino acids in its vicinity, 
especially by arginine 67, cysteine 68 is deprotonated. The resulting thiolate functions as a nucleophile 
attacking the carbonyl-C of the C-S bond in Pal-CoA. The fatty acid is then attached to cysteine 68, 
and CoA is released from Bet3. Since an acylated Bet3 molecule is no longer available for a second 
round of catalysis, this mechanism is different from a classical enzymatic reaction. However, the 
speed of the reaction in vitro, its pH and Pal-CoA requirements and the observation that Bet3 does not 
require functional DHHC proteins for its acylation inside cells [28], distinguishes self-palmitoylation 
of Bet3 from purely chemical acylation reactions described previously [19-25]. 
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Figure legends 
Figure 1: Testing the pH dependence of palmitoylation of Bet3 
A: Orthogonal views of the crystal structure of human Bet3: The covalently bound fatty acid inserted 
into the hydrophobic tunnel, amino acids mutated in this study and the single tryptophan (W 96) used 
for fluorescence spectroscopy are highlighted. 
B and C: Comparison of the self-palmitoylating activity of Bet3 mutants relative to wild-type Bet3 at 
different pH values. 
B: Equal amounts of purified wild-type GST-Bet3 (WT) and GST-Bet3 mutants containing amino-
acid substitutions at cysteine 68 (C68S, C68A) or in the vicinity of the palmitoylation site (R67E) 
were incubated with [3H]-Pal-CoA in PIPES/NaCl at pH 6.5 or Tris/NaCl buffer at pH 7.5 or 8.5 for 
20 min at 30 °C. Samples were then subjected to SDS-PAGE and fluorography. Shown are the 
resulting fluorograms and the quantification of individual bands (wt = 100%) by densitometry. 
C: Similar amounts of purified wild-type GST-Bet3 and GST-Bet3 mutants containing amino-acid 
substitutions at aspartate 70 (D70N) and glutamate 73 (E73Q) were incubated with Pal-CoA as 
described in B. Shown are the resulting fluorograms and the quantification of individual bands (D67E 
= 100%) by densitometry. 
 
Figure 2: Comparison of the self-palmitoylating activity of Bet3 mutants at different pH values. 
A: Wild-type GST-Bet3 (WT) and R67E, C68S, C68A mutants were incubated with [3H]-Pal-CoA in 
PIPES/NaCl buffer at pH 5.5, 6.5 or 7.5 or in Tris/NaCl buffer at pH 7.5, 8.5 or 9.5 for 20 min at 
30°C.  
B: Comparison of the self-palmitoylating activity of wild-type GST-Bet3 and GST-Bet3 E73Q, D70N, 
and the double mutant E73Q-D70N at different pH values as described in Figure 2A. The fluorograms 
were quantified by densitometry of bands, and relative palmitoylation (absorbance of bands at pH 9.5 
= 100%) is plotted against pH.  
Note that the strength of the self-palmitoylation reaction (intensity of bands) cannot be compared 
between wild-type and mutant Bet3 proteins, since individual fluorograms were exposed for different 
time periods. 
 
Figure 3: Self-palmitoylation of Bet3 is retarded in mutants which are less efficiently 
palmitoylated at neutral pH 
Purified GST-Bet3 proteins, wild-type and mutants as described in Fig. 1, were incubated at pH 7.5 
with [3H]-Pal-CoA for 1, 2.5, 5, 7.5, 10, 15 or 30 minutes at 30 °C prior to SDS-PAGE and 
fluorography. The fluorograms were quantified by densitometry of bands, and relative palmitoylation 
(absorbance of bands after 30 min of incubation = 100%) is plotted against the time of incubation. 
Note that individual fluorograms were exposed for different time periods, and, thus, intensity of bands 
cannot be compared between wild-type and mutant Bet3 proteins. 
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Figure 4: X-ray structural analysis of the Trs33B:Bet3C68A mutant 
A: The hydrophobic tunnel of Bet3 C68A is occupied by an elongated molecule. A prominent, 
unaccounted electron density is visible after building the peptide chain of Bet3 (upper panel: 2Fo-Fc 
map, blue at 0.9 σ contour level and Fo-Fc map, green at 3 σ contour level). Palmitate could be 
modelled into the hydrophobic channel (lower panel: 2Fo-Fc map, blue at 1.0 σ contour level). 
B: Superposition of the α2-α3 loop region of mutant Bet3 C68A (green, complex presented here) and 
wild-type Bet3 (cyan, in the Trs33A:Bet3 complex , PDB: 2C0J) which were crystallized in the same 
space group.  
 
Figure 5: Long chain acyl-CoAs inhibit self-palmitoylation of Bet3 at micromolar concentration 
A: Myristoyl-CoA, palmitoyl-CoA, stearoyl-CoA and 9-cis-oleoyl-CoA at the indicated final 
concentrations were incubated with wild-type GST-Bet3 and [3H]-Pal-CoA for 15 min at 30 °C. The 
resulting fluorograms are shown. 
B: Acetyl-CoA and octanoyl-CoA at the indicated final concentrations were incubated with wild-type 
GST-Bet3 and [3H]-Pal-CoA for 15 min at 30 °C. Note that millimolar concentrations of these CoA 
derivatives were required to reveal a slight reduction in palmitoylation. 
C: Myr-X-CoA (a non-hydrolysable Myr-CoA analog with a thioether instead of a thioester linking 
myristate and CoA) at the indicated final concentration was incubated with wild-type GST-Bet3 and 
[3H]-Pal-CoA for 15 min at 30 °C. 
 
Figure 6: Fluorescence spectroscopy to analyse binding of Acyl-CoAs to Bet3 
A: Left panel: Emission spectra of purified wild-type Bet3 between 310 nm and 410 nm. Excitation at 
295 nm. The uppermost trace represents the intrinsic tryptophan fluorescence of Bet3 in the absence of 
acyl-CoA. It is successively quenched upon addition of palmitoyl-CoA which was added in steps of 10 
µM (final concentration) to Bet3 (subsequent traces). No further reduction of the tryptophan 
fluorescence occurs at a final Pal-CoA concentration of 75 µM (undermost traces). Right panel: 
Quantitative analysis of binding of Pal-CoA to wild-type Bet3 (described in C). Error bars indicate the 
standard deviation calculated from three experiments. 
B: Left panel: Emission spectra of purified Bet3: Similar to A, but acetyl-CoA was added to Bet3 in 
steps of 1 mM (final concentration). Note that the intrinsic tryptophan fluorescence is not completely 
quenched, even at a final concentration of 10 mM acetyl-CoA. Right panel: Quantitative analysis of 
acetyl-CoA binding to wild-type Bet3 (described in C). Error bars indicate the standard deviation 
calculated from three experiments. 
C: Quantitative analysis of binding of Pal-CoA to wild-type and mutant Bet3. Fitting of fluorescence 
intensities at the emission maximum (344 nm) were normalized ((F–F0)/F0, F0: fluorescence intensity 
without ligand) and plotted against the Pal-CoA concentration. The data points were fitted and the 
number of acyl-CoA bindings sites listed in table 2 and 3 were calculated as described in materials and 
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methods. Error bars indicate the standard deviation calculated from three experiments. Where not 
indicated error bars are not larger than the symbols. 
 
Figure 7: Testing inhibitors of the self-palmitoylation reaction 
A: Palmitate or 2-bromo-palmitate at the indicated final concentrations were incubated with wild-type 
GST-Bet3 and [3H]-Pal-CoA for 15 min at 30 °C.  
B: Lyso-phosphatidylcholine, cerulenin or tunicamycin at the indicated final concentrations were 
incubated with wild-type GST-Bet3 and [3H]-Pal-CoA for 15 min at 30 °C. #: 1% chloroform, the 
solvent for the three inhibitors, was added to the sample.  
C: The designated nucleotides at the indicated final concentrations and MgCl2 (1 mM) were incubated 
with wild-type GST-Bet3 and [3H]-Pal-CoA for 15 min at 30 °C. 
 
Figure 8: Testing a Bet3 mutant with a completely blocked hydrophobic tunnel 
A: Detail of the Bet3 crystal structure showing the hydrophobic tunnel. The fatty acid is depicted as 
yellow space-filling model. The amino acids mutated in A82V-A138V to block the hydrophobic 
tunnel are modelled purple with their electron densities indicated. The tunnel is narrowed by the two 
opposing valines (V138 top, V82 bottom).  
B: CD spectra of wild-type Bet3 and Bet3 A82V-A138V indicate that the secondary structure of Bet3 
was not changed significantly by the mutation. 
C: Similar amounts of purified wild-type GST-Bet3 and GST-Bet3 A82V-A138V were incubated with 
[3H]-Pal-CoA in PIPES/NaCl at pH 6.5 or Tris/NaCl buffer at pH 7.5 or 8.5 for 20 min at 30 °C. 
D: Patches of hydrophobic amino acids at the surface of Bet3 that might bind the fatty acid of Acyl-
CoAs. The green area contains the amino acids L60, A61, V65, G66, V77, V81, L87, G88, I89, I106, 
L107, P111, G159, V160, the blue area consists of F71, I93, W96, P98, A99, G100, A145, F167, I168, 
I171. 
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Table 1 
Data collection and refinement statistics for the structure of the Trs33B:Bet3 C68A complex. 
Values in parentheses refer to the outer shell of reflections. 
 
X-ray diffraction data 
Space group P212121 
Unit cell    a [Å] 47.17 
                  b [Å] 69.26 
                  c [Å] 121.38 
Resolution [Å] 30 – 2.0   (2.1 – 2.0) 
Unique reflections 26 752   (3 311) 
Redundancy 4.05   (4.15) 
< I/σ(I) > 16.8   (3.0) 
Completeness [%] 94.9   (87.6) 
R(sym) [%] 6.3   (50.1) 
Refinement 
Resolution [Å] 25 – 2.0 
R(work) / R(free) [%] 19.7 / 23.4 
RMSD bond distances [Å] 0.009 
RMSD bond angles [°] 1.117 
Mean B value [Å2]    protein  42.2 
                                  water (100) 41.5 
                                  palmitate (1) 56.4 
Ramachandran statistics  
    Residues in most favored regions [%] 97.3 
    Residues in additionally allowed regions [%] 2.7 
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Table 2 
KD [µM] values including standard deviation for binding of various acyl-CoAs to wild-type 
Bet3 and to the non-acylated C68A mutant as calculated from at least three different 
fluorescence spectroscopy measurements.. 
 
 
 
 
 
 
 
 
 
 
 
Acyl-CoA Bet3 wt Bet3 C68A 
Stearoyl-CoA 1.3 ± 0.8 2.9 ± 0.8 
Oleoyl-CoA 2.1 ± 0.6 1.1 ± 0.3 
Palmitoyl-CoA 1.8 ± 0.7 1.6 ± 0.6 
Myristoyl-CoA 2.0 ± 0.8 2.3 ± 1.6  
Octanoyl-CoA 7252 ± 1412 11256 ± 3055 
Acetyl-CoA 7624 ± 2110 7321 ± 1327 
2-Br-Palmitate 1.3 ± 0.5 1.9 ± 0.3 
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Table 3 
KD values [µM] including standard deviation and number (#) of interaction sites for binding 
of Pal-CoA to wild-type and mutant Bet3 as calculated from at least three different 
fluorescence spectroscopy measurements. 
 
Bet3 mutant KD # of interaction sites 
wild type 1.8 ± 0.7 3.5 ± 0.2 
C68A 1.6 ± 0.6 3.3 ± 0.2 
A82V 4.0 ± 0.5 3.7 ± 0.1 
A82V-A138V 15.8 ± 2.3 2.1 ± 0.4 
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